Commentary about glucagon-like peptide-1 (GLP-1) receptor agonists is everywhere
In addition to helping with insulin resistance, these medications can benefit those with PCOS in other ways: by promoting weight loss, regulating menstrual cycles, reducing chronic inflammation, and lowering the risk of cardiovascular disease and non-alcoholic fatty liver disease, conditions that can be associated with PCOS
It is a challenge to predict the individual response to GLP-1RAs through accurate medical treatment and optimize the treatment plan accordingly
Gabriela Daz de Barboza, Laboratorio Dr
Additionally, TCM boasts the advantage of a multi-target, multi-pathway, and multi-approach strategy for treating diseases, yet limitations such as low oral bioavailability and unclear target specificity impede drug development